Table 1. Patients’ characteristics.
| Characteristic | AFP <20 ng/mL (n=466) | AFP 20–400 ng/mL (n=358) | AFP >400 ng/mL (n=358) | P value |
|---|---|---|---|---|
| Age (years) | 60.5 [26–84] | 58 [12–89] | 55 [13–82] | <0.001 |
| Sex (M:F) | 396:70 | 287:71 | 266:92 | 0.001 |
| Hepatitis status | 0.653 | |||
| No hepatitis | 67 (14.4%) | 37 (10.3%) | 40 (11.2%) | |
| Hepatitis B | 379 (81.3%) | 305 (85.2%) | 304 (84.9%) | |
| Hepatitis C | 16 (3.4%) | 14 (3.9%) | 12 (3.4%) | |
| Both | 4 (0.9%) | 2 (0.6%) | 2 (0.6%) | |
| Child Pugh grade | 0.978 | |||
| A | 450 (96.6%) | 345 (96.4%) | 346 (96.6%) | |
| B | 16 (3.4%) | 13 (3.6%) | 12 (3.4%) | |
| Presence of comorbid disease | 219 (47.0%) | 166 (46.4%) | 121 (33.8%) | <0.001 |
| Follow up (month) | 58.4 [0.3–195.1] | 53.3 [2.2–202.9] | 38.6 [0.6–202.2] | <0.001 |
AFP, alpha-fetoprotein.